Relmada Therapeutics, Inc. (RLMD)
4.31
-0.12
(-2.71%)
USD |
NASDAQ |
Jan 09, 16:00
4.30
-0.01
(-0.23%)
After-Hours: 20:00
Relmada Therapeutics Accounts Payable (Quarterly): 1.453M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 19.10M |
| Invivyd, Inc. | 18.10M |
| Arcellx, Inc. | 4.204M |
| Puma Biotechnology, Inc. | 6.386M |
| NovaBay Pharmaceuticals, Inc. | 0.076M |